Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Ramming

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Immunology Letters|August 29, 2017
Innate lymphoid cells and fibrotic regulationSteven Horsburgh, Stephen Todryk, Andreas Ramming, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular ImagingChristian Schmidkonz, Torsten Kuwert, Armin Atzinger, et al.
Expert Review of Clinical Pharmacology|April 13, 2021
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insightsMaria Gabriella Raimondo, Martina Biggioggero, Lavinia Agra Coletto, et al.
Annals of the Rheumatic Diseases|May 25, 2019
What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosisXenofon Baraliakos, Heinrich Boehm, Reza Bahrami, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2020
Microstructural Bone Changes Are Associated With Broad-Spectrum Autoimmunity and Predict the Onset of Rheumatoid ArthritisDavid Simon, Arnd Kleyer, Duy Bui Cong, et al.
Rheumatology International|July 24, 2023
Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot studySophie von Rohr, Johannes Knitza, Manuel Grahammer, et al.
Annals of the Rheumatic Diseases|February 18, 2017
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophagesChristiane Maier, Andreas Ramming, Christina Bergmann, et al.
International Journal of Molecular Sciences|July 24, 2021
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory DiseasesCharles Gwellem Anchang, Cong Xu, Maria Gabriella Raimondo, et al.
Biomedicines|March 28, 2024
Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and SpondyloarthritisRasmus S Pedersen, Jeppe Thorlacius-Ussing, Maria G Raimondo, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosisThomas Wohlfahrt, Svetlana Usherenko, Matthias Englbrecht, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Immunology Letters|August 29, 2017
Innate lymphoid cells and fibrotic regulationSteven Horsburgh, Stephen Todryk, Andreas Ramming, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular ImagingChristian Schmidkonz, Torsten Kuwert, Armin Atzinger, et al.
Expert Review of Clinical Pharmacology|April 13, 2021
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insightsMaria Gabriella Raimondo, Martina Biggioggero, Lavinia Agra Coletto, et al.
Annals of the Rheumatic Diseases|May 25, 2019
What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosisXenofon Baraliakos, Heinrich Boehm, Reza Bahrami, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2020
Microstructural Bone Changes Are Associated With Broad-Spectrum Autoimmunity and Predict the Onset of Rheumatoid ArthritisDavid Simon, Arnd Kleyer, Duy Bui Cong, et al.
Rheumatology International|July 24, 2023
Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot studySophie von Rohr, Johannes Knitza, Manuel Grahammer, et al.
Annals of the Rheumatic Diseases|February 18, 2017
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophagesChristiane Maier, Andreas Ramming, Christina Bergmann, et al.
International Journal of Molecular Sciences|July 24, 2021
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory DiseasesCharles Gwellem Anchang, Cong Xu, Maria Gabriella Raimondo, et al.
Biomedicines|March 28, 2024
Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and SpondyloarthritisRasmus S Pedersen, Jeppe Thorlacius-Ussing, Maria G Raimondo, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosisThomas Wohlfahrt, Svetlana Usherenko, Matthias Englbrecht, et al.
Pageof 10